Calreticulin Mutation Status Predicts Improved Disease Outcome in Prefibrotic Primary Myelofibrosis but Not in WHO-Defined Essential ThrombocythemiaHeinz Gisslinger, Róbert Královics, Guenther Nirnberger et al.|Blood|2014Cited by 1